Nurse Vaishali Khiran loads the measles vaccine from vials at a 2023 immunization event in Mumbra, a suburb of Mumbai, Maharashtra, India.
Photo by Prakhar Deep Jain courtesy of Gavi
|
|
Last Thursday in Brussels, Belgium, world leaders pledged more than $9 billion toward a target budget of $11.9 billion for Gavi, the Vaccine Alliance, in its next strategic period from 2026 to 2030. The commitments made at a summit convened by Gavi, the EU and the Gates Foundation come alongside other investments by development finance institutions and vaccine manufacturers, and “bring Gavi a major step closer to securing the resources it needs for Gavi 6.0,” said a press release from the summit, “in which it hopes to protect 500 million children from preventable disease, averting between 8-9 million future deaths, protecting the world from deadly outbreaks of diseases such as cholera, mpox and Ebola through its vaccine stockpiles and unlocking €85.3 billion in economic benefits for countries.”
“In a constrained budget environment, it’s even more important to focus aid funding on the investments that really work,” said Bill Gates. “And Gavi is exactly that. I don’t know of anything with a higher impact per dollar in terms of saving and improving lives. Gavi is one of the best investments I’ve ever made — and one of the best investments countries can make today in the world’s future.”
Site Selection first covered Gavi in a January 2015 newsletter article titled “Shot in the Arm.”
|
